| Filed On | Filing |
|---|---|
| 21 Oct 2026 |
Form 4: Philips Laura A, Director
Granted 8,000 Stock Options |
| 21 Oct 2026 |
Form 4: Sheinerman Kira, Director
Granted 8,000 Stock Options |
| 21 Oct 2026 |
Form 4: Sheinerman Kira, Director
Granted 8,000 Stock Options |
| 13 Oct 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
This Employment Agreement (the “Agreement”), is made by and between Niki BioSolutions, Inc., a Delaware corporation, (the “Company”) whose mailing address is 116 Village Boulevard, Suite 200, Princeton, NJ 08540 and Thomas Freeburg (the ... |
| 09 Oct 2026 | EFFECT |
| 09 Oct 2026 | PROSPECTUS SUPPLEMENT |
| 09 Oct 2026 |
8-K: Entry into a Material Definitive Agreement
Niki BioSolutions, Inc., a corporation organized under the laws of Delaware (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (“Wainwright” or the “Selling Manager”) and Brookline Capital Markets,... |
| 02 Oct 2026 | PRE-EFFECTIVE AMENDMENT NO. 3 TO FORM S-3 |
| 18 Sep 2026 | PRE-EFFECTIVE AMENDMENT 2 TO FORM S-3 |
| 14 Sep 2026 |
8-K: Other Events
Alidad Mireskandari, Ph.D. President & COO H.C. Wainwright Global Investment Conference, September 2026 NASDAQ: NIKI |
| 04 Sep 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 28 Aug 2026 | WITHDRAWAL REQUEST |
| 28 Aug 2026 | REGISTRATION STATEMENT |
| 21 Aug 2026 |
8-K/A: Financial Statements and Exhibits
We have audited the accompanying consolidated balance sheets of DiamiR Biosciences Corp. (the “Company”) as of May 31, 2026 and 2025, the related consolidated statements of operations, stockholders’ deficit and cash flows for each of the... |
| 21 Aug 2026 | 8-K: Financial Statements and Exhibits |
| 13 Aug 2026 |
Form 3: Arner Douglas Wayne, Director
Holds 1,062 shares of Common Stock |
| 13 Aug 2026 |
Form 3: Wu Justin Che Yuen, Director
Holds 1,832 shares of Common Stock |
| 07 Aug 2026 | 8-K: Other Events |
| 28 Jul 2026 |
Form 3: Mireskandari Alidad, President, & COO
No securities owned |
| 24 Jul 2026 | SCHEDULE 13D |
Loading...
